Phase III trial comparing cisplatin (C) + placebo (P) to C + anti-epidermal growth factor antibody (EGF-R) C225 in patients (pts) with metastatic/recurrent head & neck cancer (HNC). - Burtness,B.; Li,Y.; Flood,W.; Mattar,B.I.; Forastiere,A.A. (Proc Am Soc Clin Oncol, 2002)